Online Database of Chemicals from Around the World

(1E,4E)-1,5-Bis(2-methoxyphenyl)-1,4-pentadien-3-one
[CAS# 39777-61-2]

Identification
Name (1E,4E)-1,5-Bis(2-methoxyphenyl)-1,4-pentadien-3-one
Synonyms (1E,4E)-1,5-Bis(2-methoxyphenyl)penta-1,4-dien-3-one
Molecular Structure CAS # 39777-61-2, (1E,4E)-1,5-Bis(2-methoxyphenyl)-1,4-pentadien-3-one, (1E,4E)-1,5-Bis(2-methoxyphenyl)penta-1,4-dien-3-one
Molecular Formula C19H18O3
Molecular Weight 294.34
CAS Registry Number 39777-61-2
EC Number 873-543-1
Properties
Solubility Practically insoluble (0.011 g/L) (25 ºC), Calc.*
Density 1.128±0.06 g/cm3 (20 ºC 760 Torr), Calc.*
Melting point 124-126 ºC (chloroform methanol )**
* Calculated using Advanced Chemistry Development (ACD/Labs) Software V11.02 (©1994-2017 ACD/Labs)
** Ohori, Hisatsugu; Molecular Cancer Therapeutics 2006, V5(10), P2563-2571.
Safety Data
SDS Available
Market Analysis Reports
List of Reports Available for (1E,4E)-1,5-Bis(2-methoxyphenyl)-1,4-pentadien-3-one
Related Products
(E,E)-4,4'-Bis[2-(4-methoxyphenyl)ethenyl]-2,2'-bipyridine  4,4'-Bis[2-(3-methoxyphenyl)ethenyl]-2,2'-bipyridine  2-[Bis(3-methoxyphenyl)methyl]benzoic acid  (2R)-(-)-1,1-Bis(4-methoxyphenyl)-3-methyl-1,2-butanediamine  Bis[(4-methoxyphenyl)methyl] diselenide  3-[Bis(4-methoxyphenyl)methylene]-1,3-dihydro-2H-indol-2-one  N-[Bis(4-methoxyphenyl)methyl]-L-glutamine methyl ester monohydrochloride  N2,N6-Bis[(4-methoxyphenyl)methyl]-9-(1-methylethyl)-9H-purine-2,6-diamine  Bis[2-methoxy-5-[(phenylmethyl)sulfonyl]benzenediazonium] (T-4)-tetrachlorozincate  4-[3,3-Bis(4-methoxyphenyl)-3H-naphtho[2,1-b]pyran-6-yl]morpholine  1,5-Bis(4-methoxyphenyl)-1,4-pentadien-3-one  N-[1-[(2R,4R,5R)-5-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-4-[2-cyanoethoxy-[di(propan-2-yl)amino]phosphanyl]oxy-3,3-difluorooxolan-2-yl]-2-oxopyrimidin-4-yl]benzamide  N-(9-((2R,3R,4R,5R)-5-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-hydroxy-3-(2-methoxyethoxy)tetrahydrofuran-2-yl)-6-oxo-6,9-dihydro-1H-purin-2-yl)isobutyramide  N-[1-[(2R,3R,4S)-4-[Bis(4-methoxyphenyl)phenylmethoxy]tetrahydro-3-hydroxy-2-furanyl]-1,2-dihydro-2-oxo-4-pyrimidinyl]-benzamide  1-[(2R,3R,4S)-4-[Bis(4-methoxyphenyl)phenylmethoxy]tetrahydro-3-hydroxy-2-furanyl]-2,4(1H,3H)-pyrimidinedione  N-[9-[5-O-[Bis(4-methoxyphenyl)phenylmethyl]-3-O-[[bis(1-methylethyl)amino](2-cyanoethoxy)phosphino]-2-deoxy-2-fluoro-beta-D-arabinofuranosyl]-6,9-dihydro-6-oxo-1H-purin-2-yl]-2-methylpropanamide  N-[1-[5-O-[Bis(4-methoxyphenyl)phenylmethyl]-3-O-[[bis(1-methylethyl)amino](2-cyanoethoxy)phosphino]-2-deoxy-2-fluoro-beta-D-arabinofuranosyl]-1,2-dihydro-2-oxo-4-pyrimidinyl]benzamide  N-[9-[5-O-[Bis(4-methoxyphenyl)phenylmethyl]-3-O-[[bis(1-methylethyl)amino](2-cyanoethoxy)phosphino]-2-deoxy-2-fluoro-beta-D-arabinofuranosyl]-9H-purin-6-yl]benzamide  1-[5-O-[Bis(4-methoxyphenyl)phenylmethyl]-3-O-[[bis(1-methylethyl)amino](2-cyanoethoxy)phosphino]-2-deoxy-2-fluoro-beta-D-arabinofuranosyl]-2,4(1H,3H)-pyrimidinedione  (2E)-3-[9-[5-O-[Bis(4-methoxyphenyl)phenylmethyl]-3-O-[[bis(1-methylethyl)amino](2-cyanoethoxy)phosphino]-2-deoxy-beta-D-erythro-pentofuranosyl]-9H-carbazol-3-yl]-2-propenenitrile